AKT1 and metabolic dysfunction-associated steatotic liver disease: These findings suggested potential therapeutic effects on MASLD through regulation of the PI3K-Akt signaling pathway, underscoring the importance of dietary strategies and beneficial gut microbiota in MASLD management [115].